PLUS THERAPEUTICS, Inc. Common Stock
Symbol: PSTV (NASDAQ)
0.53
▼ (-11.48%) -0.069
Company Description:
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Key Stats
- Today's Open: $0.5889
- Today's High: $0.614
- Today's Low: $0.525
- Today's Volume: 13.60M
- Yesterday Close: $0.5965
- Yesterday High: $0.7067
- Yesterday Low: $0.5519
- Yesterday Volume: 89.00M
- Last Min Volume: 1.75K
- Last Min High: $0.53
- Last Min Low: $0.528
- Last Min VWAP: $0.529
Company Profile
- Name: PLUS THERAPEUTICS, Inc. Common Stock
- Website: https://www.plustherapeutics.com
- Listed Date: 2000-11-16
- Location: AUSTIN, TX
- Market Status: Active
- CIK Number: 0001095981
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $30.42M
- Round Lot: 100
- Outstanding Shares: 51.00M
- Asset Type: CS
RECENT FILINGS FOR PSTV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-25 | RW | View |
| 2025-07-21 | ARS | View |
| 2025-07-21 | DEF 14A | View |
| 2025-07-18 | 8-K | View |
| 2025-07-11 | PRE 14A | View |
| 2025-06-25 | SCHEDULE 13G/A | View |
| 2025-06-23 | EFFECT | View |
| 2025-06-23 | RW | View |
| 2025-06-23 | 424B3 | View |
| 2025-06-20 | 8-K | View |
| 2025-06-20 | S-1/A | View |
| 2025-06-18 | S-1 | View |
| 2025-06-17 | CORRESP | View |
| 2025-06-17 | 8-K | View |
| 2025-06-13 | UPLOAD | View |
| 2025-06-09 | DRS | View |
| 2025-06-06 | 8-K | View |
| 2025-05-30 | 8-K | View |
| 2025-05-30 | 10-Q | View |
| 2025-05-23 | 8-K | View |
Latest News on PSTV